Clinical Trial Update: Fangshan / Family-based Ischemic Stroke Study In China

View source ↗

Summary

An update on the Fangshan/Family-based Ischemic Stroke Study in China sponsored by Peking University, focusing on stroke; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Peking University | Conditions: Stroke | Status: UNKNOWN